154 related articles for article (PubMed ID: 38001961)
1. Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies.
Schröder L; Domroese CM; Rupp ABA; Gihr KME; Niederau C; Mallmann MR; Holdenrieder S
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001961
[TBL] [Abstract][Full Text] [Related]
2. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies].
Inoue M; Fujita Y; Abe Y; Inoue Y; Ueda G; Tanizawa O; Minagawa J; Yamada T; Ohashi K; Ozaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1799-805. PubMed ID: 4056529
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies.
Avall Lundqvist E; Nordström L; Sjövall K; Eneroth P
Eur J Gynaecol Oncol; 1989; 10(6):395-405. PubMed ID: 2627971
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.
Inoue M; Inoue Y; Hiramatsu K; Ueda G
Cancer; 1985 Jun; 55(11):2618-23. PubMed ID: 3995474
[TBL] [Abstract][Full Text] [Related]
6. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of six tumor markers in patients with benign and malignant gynecological disease.
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sato T; Takamizawa H; Wiklund B
Arch Gynecol Obstet; 1988; 243(2):61-8. PubMed ID: 3401042
[TBL] [Abstract][Full Text] [Related]
9. Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease.
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sato T; Takamizawa H; Wiklund B
Arch Gynecol Obstet; 1988; 243(1):41-50. PubMed ID: 3165614
[TBL] [Abstract][Full Text] [Related]
10. Intracystic evaluation of tumor markers in benign and malignant ovarian pathology.
Cherchi PL; Capobianco G; Ambrosini G; Fadda GM; Piga MD; Ruiu G; Fattorini F; Dessole S
Eur J Gynaecol Oncol; 2002; 23(2):163-5. PubMed ID: 12013118
[TBL] [Abstract][Full Text] [Related]
11. The application value of the detection of the level of tissue polypeptide antigen, ovarian cancer antigen X1, cathepsin L and CA125 on the diagnosis of epithelial ovarian cancer.
Lv XL; Zhu Y; Liu JW; Ai H
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5113-5116. PubMed ID: 28051260
[TBL] [Abstract][Full Text] [Related]
12. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Escudero JM; Auge JM; Filella X; Torne A; Pahisa J; Molina R
Clin Chem; 2011 Nov; 57(11):1534-44. PubMed ID: 21933899
[TBL] [Abstract][Full Text] [Related]
15. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
Wu L; Sun J; Wang X
Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection.
Berek JS; Bast RC
Cancer; 1995 Nov; 76(10 Suppl):2092-6. PubMed ID: 8635006
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
[TBL] [Abstract][Full Text] [Related]
19. [The assessment of the dependence between antigen CA 125 and nicotinism in patients with benign ovarian tumors including endometrial cysts].
Posadzka E; Jach R; Babczyk D; Knafel A; Pityński K
Przegl Lek; 2014; 71(6):319-22. PubMed ID: 25344972
[TBL] [Abstract][Full Text] [Related]
20. Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours.
Ghazizadeh M; Sasaki Y; Oguro T; Aihara K; Tenjin H; Araki T
Histopathology; 1990 Aug; 17(2):123-8. PubMed ID: 2227836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
